STSanjeev Varghese Thomas

Sanjeev Varghese Thomas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sanjeev Varghese Thomas has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy

    by Anne Sabers, Dina Battino, Erminio Bonizzoni, John Craig, Dick Lindhout, Emilio Perucca, Sanjeev V. Thomas, Torbjörn Tomson, Frank Vajda


  • Open Access

    Teratogenic effects of carbamazepine in mice

    by Sanjeev Varghese Thomas, Manna Jose, Harikrishnan Vijayakumar Sreelatha, Manjula Valiyamattathil James, Sabareeswaran Arumughan

    Objectives: The aim of this study was to determine the teratogenic effects of carbamazepine (CBZ) in BALB/c mice. Materials and Methods: Mature female and male BALB/c mice (25–30 g) were used for all experiments. After standardization of administration and dose of CBZ, animals in the CBZ-treated groups (CBZ 450 mg/kg and 600 mg/kg) were fed on medicinal diet. The dams in the control group were mated on the same day as that of the CBZ-treated dams. After cesarean section (CS), fetal viability status and weights were recorded. Gross histopathological examination of fetuses was conducted to identify alterations in morphology and external or internal organs due to in utero exposure of CBZ. Results: Out of the nine female animals (three treated on CBZ 450 mg/kg, three treated on CBZ 600 mg/kg and three controls), seven were pregnant, and two (one each from the two CBZ-treated groups) were nonpregnant. All fetuses of the control group (n = 31) and CBZ 450 mg/kg treated group (n = 24) were live, but eight out of the twenty fetuses (40%) of CBZ 600 mg/kg treated group were dead at CS. The birth weight of the fetuses antenatally exposed to CBZ was drastically reduced (0.71 ± 0.06) when compared to control fetuses (1.67 ± 0.12) (P < 0.0001). All the fetuses of the CBZ-treated groups showed stunted physical development. Conclusion: Although oral administration of CBZ to mice is a convenient model to study the effect of CBZ to pregnancy, higher oral dose was associated with increased fetal loss. Some of the fetuses exposed to CBZ demonstrated structural abnormalities and low body weight.


    • 1 August 2013
      • Vol. 61, 48-51

    Women with epilepsy in reproductive age group: special issues and management strategies.

    by Shehanaaz Begum, Sanjeev V Thomas

    Women with epilepsy (WWE) have several gender based problems pertaining to social and biological domains. The stigma of epilepsy and its consequences appear to be more for women than men. They have more difficulty in getting married and sustaining a married life. The cyclical variations in the reproductive hormones can adversely impact the seizure pattern in WWE. Epileptiform discharges in the brain can influence the hypothalamic functions and lead to sexual dysfunction. The Antiepileptic drugs (AED) may alter their metabolic and hormone profile and contribute to this disorder. Most WWE tend to have uneventful pregnancies and healthy babies. Nevertheless, the risk of fetal malformations appears to be increased when AEDs are used during pregnancy. This risk is higher for those who are on polytherapy, or using valproate. Recent studies have also demonstrated that antenatal exposure to AEDs could lead to neurocognitive and developmental impairment, low IQ or language problems in exposed infants. Clinicians need to consider these special issues while initiating AED therapy in adolescent girls. All WWE need to have a detailed pre conception evaluation wherein the need to continue AEDs, the ideal AED and dosage are reassessed. The AED therapy would have to be individualized according to the clinical situations, obstetric background and family concerns. Folic acid should be prescribed to all women who could potentially become pregnant. Detailed screening for fetal malformations by estimation of serum alpha fetoprotein and fetal ultrasonography need to be carried out between 14 - 18 weeks of pregnancy. The dosage of AEDs may have to be escalated in the second half of pregnancy in selected patients. The family should be provided detailed counseling and information on how to cope with the pregnancy, childbirth, lactation, and contraception.


    • 1 July 2008
      • Vol. 11  (3) , 196
    Open Access

    A majestic morning walk...!

    by Sanjeev V Thomas

  • Cardiac Malformations Are Increased in Infants of Mothers with Epilepsy

    by S. V. Thomas, B. Ajaykumar, K. Sindhu, E. Francis, N. Namboodiri, S. Sivasankaran, J. A. Tharakan, P. S. Sarma

    We aimed to ascertain the prevalence of cardiac malformation (CM) and its association with antenatal exposure to an antiepileptic drug (AED) in infants of mothers with epilepsy (IMEs). Women with epilepsy (WWE) are enrolled in Kerala Registry of Epilepsy and Pregnancy (KREP) in the prepregnancy or early pregnancy period and are followed up with a standard protocol until the IMEs are 6 years old. At 3 months postpartum, a cardiologist, blinded to the AED exposure, carried out a clinical examination and echocardiography on all live-born babies. Patent foramen ovale (PFO) and interatrial septal defects of < 5 mm in size were excluded from CM. Details of maternal epilepsy, folate usage, AED exposure in the first trimester, and newborn characteristics were abstracted from the records of the KREP. We examined 462 babies. Maternal epilepsy was generalized in 201 (43.50%) or localization related in 241 (52.2%). The AED exposure was monotherapy in 262 (56.7%)—carbamazepine (112), valproate (71), phenobarbitone (43), phenytoin (31), and clonazepam (2)—and polytherapy in 126 (27.3%). Seventy-four infants (16.01%) had no AED exposure. There were 36 infants with CM (7.8%; 95% confidence interval: 5.5–10.6). CMs included atrial septal defect (26; 72.2%), tetrology of Fallot (3; 8.3%), patent ductus arteriosus and pulmonic stenosis (2 each; 5.6%), and ventricular septal defect, tricuspid regurgitation, transposition of great arteries (1 each; 2.8%). CMs were significantly more for IMEs with premature birth (p < .003). There was no association between CM and maternal age, epilepsy syndrome, seizure frequency during pregnancy, and folate use. CMs were more frequent with polytherapy (13; 10.3%) compared to monotherapy (17; 6.5%). Those with valproate exposure had a trend (not statistically significant) toward higher frequency of CM compared to IMEs on other AEDs as monotherapy.


    • 1 January 2008
      • Vol. 11  (1) , 55
    Open Access

    An all time inspiration.

    by Sanjeev V Thomas

  • Open Access

    Climate, health and disease

    by Sanjeev V Thomas

    Ann Indian Acad Neurol, Official publication of Indian Academy of Neurology.

  • Open Access

    Lipid peroxidation in women with epilepsy

    by Sanjeev V Thomas, D Deepa, B Jayakumari

    Ann Indian Acad Neurol, Official publication of Indian Academy of Neurology.


  • Open Access

    More than a silent Tsunami every year

    by Sanjeev V Thomas

    Ann Indian Acad Neurol, Official publication of Indian Academy of Neurology.

  • Focal neuronal loss, reversible subcortical focal T2 hypointensity in seizures with a nonketotic hyperglycemic hyperosmolar state

    by S. Raghavendra, R. Ashalatha, Sanjeev V. Thomas, C. Kesavadas

    Introduction Neuroimaging in seizures associated with nonketotic hyperglycemia (NKH) is considered normal. We report magnetic resonance imaging (MRI) abnormalities in four patients with NKH and seizures. Methods We prospectively evaluated clinical and radiological abnormalities in four patients with NKH during the period March 2004 to December 2005. Results All patients presented with seizures, either simple or complex partial seizures or epilepsia partialis continua. Two of them had transient hemianopia. MRI showed subcortical T2 hypointensity in the occipital white matter and in or around the central sulcus (two patients each), T2 hyperintensity of the overlying cortex (two patients), focal overlying cortical enhancement (three patients) and bilateral striatal hyperintensity (one patient). Diffusion-weighted imaging (DWI) performed in three patients showed restricted diffusion. The ictal semiology and electroencephalographic (EEG) findings correlated with the MRI abnormalities. On clinical recovery, the subcortical T2 hypointensity and striatal hyperintensity reversed in all patients. The initial cortical change evolved to FLAIR hyperintensity suggestive of focal cortical gliosis. The radiological differential diagnosis considered initially included encephalitis, malignancy and hemorrhagic infarct rendering a diagnostic dilemma. Conclusion We identified subcortical T2 hypointensity rather than hyperintensity as a characteristic feature of seizures associated with NKH. Only very few similar reports exist in literature. Reversible bilateral striatal T2 hyperintensity in NKH has not been reported to the best of our knowledge.